Ascendia

  MARKET NEWS

Nemera’s Multi-Dose Eyedropper for Preservative-Free Formulations Approved With Haohai Qisheng for Dry Eye in China
Sharp Services Makes Significant Investment to Expand Injectables Packaging Capacity at its European Facilities
Levicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis
Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis 
Sever Pharma Solutions Announces Appointment of New VP of Quality
Copley Scientific Launches New Platform for Inhaled Product Testing
Proveris Joins Investindustrial to Support Customers & Long-Term Growth
Datwyler, LTS Device Technologies & Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs
Nicoya Life Sciences Announces Launch of Multichannel Benchtop SPR Instrument, Aimed to Deliver Publication-Quality, Real-time Kinetic Data to Small & Midsize Research Labs
Vetter Reaches Key Launch Milestones for the V-OVS next Tamper-Evident Syringe Closure System

  EXPERT CONTENT & RESOURCES

Dr. Joseph Sinkule, Founder, Chairman of the Board and CEO of Klotho Neurosciences

Klotho Neurosciences: Focused on Neurodegenerative & Age-Related Disorders

Dr. Joseph Sinkule, CEO of Klotho Neurosciences, discusses the company, its therapies, the human Klotho gene, and longevity.

Operational Excellence at Scale: Why Integrated Manufacturing is the Future Biopharmaceutical Standard

Operational Excellence at Scale: Why Integrated Manufacturing is the Future Biopharmaceutical Standard

Pierre Catignol explains how the conventional model creates friction when the industry needs fluidity, and integrated manufacturing answers that call by converting logistical complexity into a reliable operating rhythm that clients trust.

Enabling a Breakthrough in Ophthalmology: A Case Study in Collaboration Between a Biotech & Device Manufacturer on a Novel Drug Delivery System

Enabling a Breakthrough in Ophthalmology: A Case Study in Collaboration Between a Biotech & Device Manufacturer on a Novel Drug Delivery System

Ashwin Agarwal, CFO of Azura Ophthalmics and John Merhige, Co-CEO of Credence MedSystems, share an inside look at how two partners are aligning technical and regulatory strategies, integrating complementary expertise, and collaborating effectively to deliver an innovative ophthalmic combination product and inform future biotech–device partnerships.

  FEATURED EDITORIAL

  COMPANY PROFILE

Halo Pharma is a leading provider of pharmaceutical services, including contract dosage form development, commercial manufacturing and analytical services. Our capabilities in the areas of tech transfer, process and pharmaceutical product development, formulation development, production, scale-up and validation, and analytical method development allow us to partner with clients from development through commercialization or at any point along the way. Click here for more.

  WHITEPAPERS & WEBINARS

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

Honeywell Aclar® thermoformable film enables pharmaceutical and medical device companies to achieve their sustainability commitments.

Aclar® film not only delivers a high moisture barrier to protect medicines, but it also reduces pack size, reduces waste, and reduces carbon emissions, compared

…

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

By: Dr. Bahar Yeniad and Dr. Pieter van Delft

Experts in copolymer microstructures have an important role to play in selecting biomaterials that can deliver desired performance of (bio)medical products. But how does microstructure link to the rate of API …

WHITEPAPER - Streamline Early-Stage Development to Reach the Clinic Faster

WHITEPAPER - Streamline Early-Stage Development to Reach the Clinic Faster

Early-stage development is critical to shortening your product’s timelines while establishing a solid foundation for clinical trials. In this insightful article from Dr. Srinivasan Shanmugam, Adare’s Executive Director of Pharmaceutical Sciences, learn what’s needed to make your product’s early-stage development …

WHITEPAPER - Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations

WHITEPAPER - Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations

Abstract

Intradermal delivery has long been a critical method in medical and pharmaceutical fields, offering unique advantages for diagnosis, vaccination and therapeutic applications. This white paper explores the evolution of intradermal delivery methods, comparing historic methods of delivery such as …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

January 28 – Bioavailability
February 4 – Analytical Testing